Primary (not associated with other autoimmune disorders) APS patients have higher levels of tyrosine nitrated β2GPI, which cannot inhibit vWF-platelet binding compared to the non-nitrated form [55]. This evidence concerns the gene APOH and autoimmune polyendocrinopathy.